medigraphic.com
SPANISH

Acta Científica Estudiantil

Órgano Científico Oficial de SOCIEM-UCV
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2008, Number 4

<< Back Next >>

Acta Cient Estud 2008; 6 (4)

Relación entre Consanguinidad y Glucogenosis Tipo IV en una Familia del Medio Rural

Herrera-Martínez AD, Henríquez-Recine MA, Estrada CPR
Full text How to cite this article

Language: Spanish
References: 20
Page: 206-215
PDF size: 129.64 Kb.


Key words:

Consanguinity, amylopectin, intracitoplasmatic inclusions PAS (+).

ABSTRACT

Consanguinity relationships in our rural population is a frequent practice which have tendency to be expressed like pathologies with autosomic recessive inheritance, most of them compromise patient’s life. One of these disorders, with a metabolic basis, is Glycogen storage disease type IV, not a common disease, in which there is a deficiency of the hepatic branching enzyme resulting at abnormal glycogen production that resembles an amylopectin-like structure; it accumulates in all tissues specially liver, skeletal muscle, brain, spinal cord and heart, by the way, this disorder is considered a systemic disease. It’s hepatic presentation curses with growth detention, hepatosplenomegaly, abdominal distention, hypotonia, wickness and muscular atrophy, hyporreflexia, progressive liver cirrhosis, portal hypertension, ascites, liver failure and early death. This is the case of a patient product of consanguineous parents in second generation with antecedent of: mother with two previous aborts, three dead sibs with hepatosplenomegaly; one of them with initial diagnosis of Gaucher Disease type I, nevertheless the autopsy revealed an extended cirrhosis and intracitoplasmatic inclusions PAS (+) at hepatocytes, spleen’s and brain’s cells suggesting Glycogen Storage Disease type IV. The patient had short stature (p10), hepatosplenomegaly, axial hypotonia, hyporrefelexia and psychomotor’s development delay, these signs correspond to the previously described pathology. She was hospitalized in several opportunities by acid base disorders without response to treatment; she died at the age of two years without definitely diagnosis which was clarified thanks to retrospective investigation of brother’s autopsy.


REFERENCES

  1. Andersen, D. H. : Familial cirrhosis of the liver with storage of abnormal glycogen. Lab. Invest. 5: 11-20, 1956.

  2. Bao, Y.; Kishnani, P.; Wu, J.-Y.; Chen, Y.-T. : Hepatic and neuromuscular forms of glycogen storage disease type IV caused by mutations in the same glycogenbranching enzyme gene. J. Clin. Invest. 97: 941-948, 1996.

  3. Beutler, E.; Kuhl, W.; Sorge, J. : Glucocerebrosidase 'processing' and gene expression in various forms of Gaucher disease. Am. J. Hum. Genet. 37: 1062- 1070, 1985.

  4. Brown, B. I.; Brown, D. H. : Branching enzyme activity of cultured amniocytes and chorionic villi: prenatal testing for type IV glycogen storage disease. Am. J. Hum. Genet. 44: 378-381, 1989.

  5. Chen YT Glycogen Storage Diseases. The metabolic and molecular bases of inherited diseases. Mc Graw Hill 2.001: 1521-52

  6. Crocker, A. C.; Farber, S. : Niemann-Pick disease: a review of eighteen patients. Medicine 37: 1-95, 1958

  7. Desnick, R. J.; Dawson, G.; Desnick, S. J.; Sweeley, C. C.; Krivit, W. : Diagnosis of glycosphingolipidoses by urinary-sediment analysis. New Eng. J. Med. 284: 739- 744, 1971.

  8. Forsythe, W. I.; McKeown, E. F.; Neill, D. W. : Three cases of Niemann-Pick's disease in children. Arch. Dis. Child. 34: 406-409, 1959.

  9. Grabowski, G. A.; Dinur, T.; Osiecki, K. M.; Kruse, J. R.; Legler, G.; Gatt, S. : Gaucher disease types 1, 2, and 3: differential mutations of the acid betaglucosidase active site identified with conduritol B epoxide derivatives and sphingosine. Am. J. Hum. Genet. 37: 499-510, 1985.

  10. Goldblatt, J.; Sacks, S.; Dall, D.; Beighton, P. : Total hip arthroplasty in Gaucher's disease: long-term prognosis. Clin. Orthop. 228: 94-98, 1988.

  11. Howell, R. R.; Kaback, M. M.; Brown, B. I. : Type IV glycogen storage disease: branching enzyme deficiency in skin fibroblasts and possible heterozygote detection. J. Pediat. 78: 638-642,1.971.

  12. Lanir, A.; Hadar, H.; Cohen, I.; Tal, Y.; Benmair, J.; Schreiber, R.; Clouse, M. E. : Gaucher disease: assessment with MR imaging. Radiology 161: 239-244, 1986.

  13. Pentchev, P. G.; Neumeyer, B.; Svennerholm, L.; Groth, C. G.; Brady, R. O. : Immunological and catalytic quantitation of splenic glucocerebrosidase from the three clinical forms of Gaucher disease. Am. J. Hum. Genet. 35: 621-628, 1983.

  14. Raiman E Cornejo B. Defectos en la Oxidacion de acidos grasos productora de hipoglicemia no cetósica en los niños. Rev Chil Nutrición; 2.007. 34 001

  15. Raghavan, S. S.; Topol, J.; Kolodny, E. H. : Leukocyte beta-glucosidase in hetomozygotes and heterozygotes for Gaucher disease. Am. J. Hum. Genet. 32: 158-173, 1980.

  16. Selby, R.; Starzl, T. E.; Yunis, E.; Brown, B. I.; Kendall, R. S.; Tzakis, A. : Liver transplantation for type IV glycogen storage disease. New Eng. J. Med. 324: 39-42, 1991.

  17. Shin, Y. S.; Steiguber, H.; Klemm, P.; Endres, W.; Schwab, O.; Wolff, G. : Branching enzyme in erythrocytes: detection of type IV glycogenosis homozygotes and heterozygotes. J. Inherit. Metab. Dis. 11 (suppl. 2): 252-254, 1988.

  18. Sorrell MF, Maddrey WC. Liver disease in infancy and childhood. Schiff’s Disease of the Liver; Publicaciones Lippincott- Raven; 1.999; capítulo 59. 2:1.357-512

  19. Starzl, T. E.; Demetris, A. J.; Trucco, M.; Ricordi, C.; Ildstad, S.; Terasaki, P. I.; Murase, N.; Kendall, R. S.; Kocova, M.; Rudert, W. A.; Zeevi, A.; Van Thiel, D. : Chimerism after liver transplantation for type IV glycogen storage disease and type 1 Gaucher's disease. New Eng. J. Med. 328: 745-749, 1993.

  20. Wiedemann, H. R.; Gerken, H.; Graucob, E.; Hansen, H. G.: Recognition of heterozygosity in sphingolipidoses. (Letter) Lancet I: 1283, 1965.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Acta Cient Estud. 2008;6